Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort

American Journal of Epidemiology

Volumn 154, Issue 7, 2001, Pages 635-641

  Luchsinger, Jose A ^a,b   Tang, Ming Xin ^a,c   Stern, Yaakov ^a,b,d   Shea, Steven ^b,c   Mayeux, Richard ^a,b,c,d  

^a Columbia University ^*  (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c Department of Medicine   (United States)

^d Vagelos College of Physicians and Surgeons   (United States)

Author keywords

Alzheimer disease; Dementia; Diabetes mellitus; Survival analysis

Indexed keywords

DIABETES; DISEASE PREVALENCE; ETHNICITY; HEALTH RISK;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; OUTCOMES RESEARCH; PREVALENCE; RISK ASSESSMENT; STROKE;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; DEMENTIA, VASCULAR; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HISPANIC AMERICANS; HUMANS; LONGITUDINAL STUDIES; MALE; NEW YORK CITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 0035479310     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/154.7.635     Document Type: Article

References (55)

1. Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported
2. Evaluation of dementia
3. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The third national health and nutrition examination survey, 1988-1994
4. Diabetes in America: Epidemiology and scope of the problem
5. The ApoE-ε4 allele and the risk of Alzheimer's disease among African Americans, whites, and Hispanics
6. Relative rates of dementia by multiple case definitions, over 2 prevalence periods, in 3 cultural groups
7. Differences in rates of dementia between ethnoracial groups
8. The apolipoprotein ε4 allele in patients with Alzheimer's disease
9. Apolipoprotein-E and Alzheimer's disease: Ethnic variation in genotypic risks
10. Relative risk of Alzheimer's disease and age-at-onset base of APOE genotypes among elderly African Americans, Caucasians and Hispanics in New York City
11. Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent
12. Lack of an association between apolipoprotein E ε4 and Alzheimer's disease in elderly Nigerians
13. Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort
14. Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study
15. Neuropathological assessment of the lesions of significance in vascular dementia
16. Low-density lipoprotein cholesterol and the risk of dementia with stroke
17. Status of risk factors for dementia associated with stroke
18. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study
19. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases
20. Diabetes and Alzheimer's disease: Glycation as a biochemical link
21. NIDDM and blood pressure as risk factors for poor cognitive performance: The Framingham Study
22. Is diabetes associated with cognitive impairment and cognitive decline among older women?
23. Association of diabetes mellitus and dementia: The Rotterdam Study
24. Risk of dementia among persons with diabetes mellitus: A population-based cohort study
25. Vascular risks and incident dementia: Results from a cohort study of the very old
26. Diabetes mellitus and the risk of dementia: The Rotterdam Study
27. Clinical criteria for the diagnosis of vascular dementia: A multicenter study of comparability and interrater reliability
28. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance
29. Diagnosis of dementia in a heterogeneous population. I: Development of a neuropsychological paradigm and quantified correction for education
30. A new clinical scale for the staging of dementia
31. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
32. Restriction isotyping of human lipoprotein E by gene amplification and cleavage of HhAI
33. Cholesterol determination in high-density lipoproteins separated by three different methods
34. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
35. Time-to-event analysis of longitudinal follow-up of a survey: Choice of the time-scale
36. Mild cognitive impairment: Conceptual basis and current nosological status
37. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts
38. Clinical determinants of dementia related to stroke
39. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort
40. Cerebral and ophthalmic artery hemodynamic responses in diabetes mellitus
41. Impairment of cerebrovascular reactivity in long term type 1 diabetes
42. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein
43. Toxic effects of a betaamyloid peptide (beta 22-35) on the hippocampal neuron and its prevention
44. Immunohistochemical colocalization of amyloid precursor protein with cerebrovascular amyloid of Alzheimer's disease
45. The molecular pathology of amyloid deposition in Alzheimer's disease
46. Neuronal origin of cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels
47. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome
48. The molecular pathogenesis of Alzheimer's disease: Clinical prospects
49. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
50. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop
51. Type-2 diabetes and cognitive function in a non-demented population